The effects of a 6-week intervention with Limosilactobacillus reuteri ATCC PTA 6475 alone and in combination with L. reuteri DSM 17938 on gut barrier function, immune markers, and symptoms in patients with IBS-D-An exploratory RCT ( vol 19 , e0312464 , 2024)

Authors
Category Primary study
JournalPLOS ONE
Year 2025
[This corrects the article DOI: 10.1371/journal.pone.0312464.].
Epistemonikos ID: 82369d2a480a93f0ebd5d2b710cec62bca3f80cc
First added on: Mar 07, 2025